Kedrion is a plasma-derived pharmaceutical product used to treat deficiencies of certain important blood proteins, such as clotting factors. It is essential for patients with hereditary bleeding disorders such as hemophilia, helping to effectively compensate for the deficiency and improve blood function.
The treatment should be used under medical supervision because Kedrion contains components extracted from blood and may require close monitoring during treatment to avoid any adverse reactions and ensure patient safety and a safe and effective response to treatment.